[CONTRIBUTION TO EVALUATION OF THERAPY OF PSORIASIS WITH TRIAMCINOLONE, ANABOLIZING DRUGS AND ORAL ANTIDIABETICS].
D000293:Adolescent; D035843:Biomedical Research; D002648:Child; D004358:Drug Therapy; D007004:Hypoglycemic Agents; D008696:Methandrostenolone; D011565:Psoriasis; D014044:Tolbutamide; D014221:Triamcinolone
D007004:Hypoglycemic Agents; D014221:Triamcinolone; D014044:Tolbutamide; D008696:Methandrostenolone
ADOLESCENCE; CHILD; CLINICAL RESEARCH; DRUG THERAPY; METHANDROSTENOLONE; PSORIASIS; TOLBUTAMIDE; TRIAMCINOLONE
CONTRIBUTO ALLA VALUTAZIONE DELLA TERAPIA DELLA PSORIASI CON TRIAMCINOLONE, ANABOLIZZANTI ED ANTIDIABETICI ORALI.